logo
logo

Dren Bio Announces $65 Million Series B Financing To Advance Its Lead Asset Into The Clinic And To Accelerate Development Of New Product Candidates From Its Targeted Myeloid Engager And Phagocytosis Platform

Jun 14, 2022about 3 years ago

Amount Raised

$65 Million

Round Type

series b

Foster City

Description

Dren Bio, Inc. (“Dren Bio” or the “Company”) today announced the completion of their $65 million Series B financing, pushing the Company’s total capital received to date over $156 million. Following the financing, Dren Bio is well-capitalized to reach multiple key inflection points across both its drug discovery programs over the coming years.

Company Information

Company

Dren Bio

Location

Foster City, California, United States

FundzWatch™ Score

68
Medium Activity

Buyer Intent Analysis

Get personalized insights on buying likelihood

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Related People